Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer

Clinical trial NCT06081959 · RECRUITING

Trial details

NCT number: NCT06081959
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2023-10-31
Primary completion: 2026-12-31
Enrollment: 376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.